Division of Gastroenterology

David Morgan


Associate Professor, Division of Gastroenterology, Department of Medicine

Member, Division of Gastroenterology

Head, Service of Gastroenterology, St. Joseph´s Hospital, Hamilton

Administrative Assistant: Deborah Urbanowicz

Academic Interests

Dr. David Morgan completed his undergraduate training in Human Genetics at McGill University. He did graduate studies including a Masters in Population Genetics. Undergraduate medical studies were completed at McMaster University and post-graduate studies including Internal Medicine and Gastroenterology, were also completed at McMaster. Dr. Morgan took an additional fellowship year with special attention paid to advanced endoscopic techniques, including YAG laser.

Dr. Morgan was previously the President of the CAG and was on the CAG Executive and Board of Directors. He is currently a member of the OAG Executive and Board of Directors.

Dr. Morgan has acted as a reviewer for many journals. Dr. Morgan is on the faculty at McMaster University and is involved in teaching at the undergraduate and post-graduate levels. He serves on many university and hospital committees. Dr. Morgan is Head of the Service of Gastroenterology and Deputy Chief of Medicine at St. Joseph´s Hospital, Hamilton.

He has published on such topics such as GI bleeding, quality of life in cancer care, use of proton pump inhibitors and the prevention of bleeding from GI vascular lesions.

Research Interests

Dr. Morgan´s research interests include dyspepsia, particularly with regards to effects of non-steroidal anti-inflammatory drugs. Other research areas include colon cancer prevention with COX-2 specific inhibitors and upper GI bleeding, particularly with relation to non-steroidal anti-inflammatory drug use.

Selected Publications

  1. Schoenfeld P, Guyatt G, Hamilton F, Laine L, Cook D, Bjorkman D, Morgan DG, Peterson W:  An Evidence-Based Approach to Gastroenterology Diagnosis.  Gastroenterology 116:1230-1237 (1999).
  2. Zhao SZ, Arguelles LM, Dedhiya SD, Morgan DG:  Healthcare Utilization Associated with Dyspepsia in Patients with Arthritis.  The American Journal of Managed Care Vol. 5, No. 10: 1285-1293 (1999).
  3. Borgaonkar MR, Morgan DG:  Primary Biliary Cirrhosis and Type II Autoimmune Polyglandular Syndrome.  Can J Gastroenterol Vol. 13 No. 9:767-770 (1999).
  4. Hunt, RH, Barkun AN, Baron D, Bombardier C, Bursey FR, Marshall JR, Morgan DG, Pare P, Thomson ABR, Whittaker JS:  Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs:  Defining the role of gastroprotective agents.  Can J Gastroenterol  Vol. 16 No. 4:231-240 (2002).
  5. Morgan D:  Intravenous proton pump inhibitors in the critical care setting.  Crit Care Med  Vol. 30, No. 6 (Suppl.):S369-S372 (2002).
  6. Warkentin TE, MooreJC, Anand SS, Lonn EM, Morgan DG:  Gastrointestinal Bleeding, Angiodysplasia, Cardiovascular Disease, and Acquired von Willebrand Syndrome.  Transfusion Medicine Reviews Vol. 17, No. 4:272-286 (2003).
  7. Leddin D, Hunt R, Champion M, Cockeram A, Flook N, Gould M, Kim YI, Love J, Morgan D, Natsheh S, Sadowski D, for the Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation committee on colon cancer screening:  Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation:  Guidelines on Colon Cancer Screening.  Can J Gastroenterol Vol. 18 No. 2:93-99 (2004).
  8. Morgan DG, Atin M, Aumais G, Cockeram A, Habal F, Switzer C, Wolman S:  Increasing Versatility of PPIs:  The Place of Orally Disintegrating Lansoprazole.  The Canadian Journal of Diagnosis Vl. 23 No. 11:101-18(2006)